BioWorld

Sep. 18, 2008

View Archived Issues

Biovail Gains Newly Approved HD Drug in $100M Prestwick Buyout

A month after winning FDA approval for its first drug, privately held Prestwick Pharmaceuticals Inc. was acquired by Canadian drugmaker Biovail Corp. in a $100 million deal. (BioWorld Today) Read More

Depomed Starts Hot Flash Phase III for Gabapentin GR

Read More

TLR-Independent, Intracellular Innate Immunity Activator Found

Read More

FDA Wants More Data for Gilead's CF Infection Drug

Read More

Other News To Note

Read More

Financings Roundup

Read More

Clinic Roundup

Read More